- Home
- PGEN vs GHI Comparison
PGEN vs GHI Comparison
Compare PGEN & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- GHI
- Stock Information
- Founded
- PGEN 1998
- GHI 1998
- Country
- PGEN United States
- GHI United States
- Employees
- PGEN N/A
- GHI N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- GHI Finance: Consumer Services
- Sector
- PGEN Health Care
- GHI Finance
- Exchange
- PGEN Nasdaq
- GHI Nasdaq
- Market Cap
- PGEN 292.6M
- GHI 287.2M
- IPO Year
- PGEN N/A
- GHI N/A
- Fundamental
- Price
- PGEN $0.78
- GHI $11.05
- Analyst Decision
- PGEN Buy
- GHI Strong Buy
- Analyst Count
- PGEN 5
- GHI 4
- Target Price
- PGEN $7.00
- GHI $17.50
- AVG Volume (30 Days)
- PGEN 922.5K
- GHI 116.5K
- Earning Date
- PGEN 11-14-2024
- GHI 11-06-2024
- Dividend Yield
- PGEN N/A
- GHI 13.42%
- EPS Growth
- PGEN N/A
- GHI N/A
- EPS
- PGEN N/A
- GHI 0.61
- Revenue
- PGEN $3,963,000.00
- GHI $34,307,528.00
- Revenue This Year
- PGEN N/A
- GHI N/A
- Revenue Next Year
- PGEN $426.76
- GHI $10.35
- P/E Ratio
- PGEN N/A
- GHI $17.99
- Revenue Growth
- PGEN N/A
- GHI 28.98
- 52 Week Low
- PGEN $0.76
- GHI $10.77
- 52 Week High
- PGEN $1.93
- GHI $17.48
- Technical
- Relative Strength Index (RSI)
- PGEN 39.38
- GHI 32.39
- Support Level
- PGEN $0.76
- GHI $10.77
- Resistance Level
- PGEN $0.97
- GHI $11.96
- Average True Range (ATR)
- PGEN 0.07
- GHI 0.29
- MACD
- PGEN -0.01
- GHI -0.02
- Stochastic Oscillator
- PGEN 7.90
- GHI 21.21
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.